Your browser doesn't support javascript.
loading
Efficacy and tolerability of classical and polyunsaturated fatty acids ketogenic diet in controlling paediatric refractory epilepsy - A randomized study.
Ray, Subhasree; Nathan, Janak; Godhia, Meena.
Affiliation
  • Ray S; Corporate Medical Services, Reliance Industries Limited, Mumbai, India. Electronic address: subhasree.ray@ril.com.
  • Nathan J; Neurology, Shushrusha Hospital, Mumbai, India.
  • Godhia M; Food Sc. & Nutrition, S.N.D.T. Women's University, Mumbai, India.
Epilepsy Res ; 204: 107395, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38908324
ABSTRACT

OBJECTIVES:

To measure and compare the efficacy and tolerability of a classical ketogenic diet (CKD) and a polyunsaturated fatty acids ketogenic diet (PUFAKD) in managing childhood refractory epilepsy. Efficacy was assessed by measuring the change in seizure frequency at 3, 6, 9, and 12 months within and between groups. The percentage reduction in seizures at <50 %, 50-90 %, >90 %, and 100 % was also measured. Tolerability was assessed and compared by recording adverse events - vomiting, nausea, lethargy, and constipation.

METHODS:

52 children, aged 2-10 years, were randomized, 25 in the CKD group and 27 in the PUFAKD group. Fat carbohydrate + protein ratio of 2.21-41 was maintained in both diets; the PUFAKD group only used unsaturated fats with an omega 3 omega 6 ratio of 12.8. Ketone levels were measured using keto-dipsticks, with 4+ and 4++ (80-160 mg/dL) being the most optimal values.

RESULTS:

A significant decrease (p=0.001) in seizures was observed (n=52), with no significant difference (p=0.537) between the two groups. The mean seizure reduction was 71.1 %, with no significant difference (p=0.488) in both groups. The mean compliance rate was 78.3 % (n=52). A statistically significant linear trend existed between a higher compliance rate and a greater reduction in seizures (p = 0.042, Z=4.039) among all children (n=52). Nausea (p=0.033) and vomiting (p=0.014) occurred more in PUFAKD than in CKD.

CONCLUSION:

No significant difference was seen in seizure reduction between the two groups. Compliance correlates with a greater seizure reduction. Despite similar seizure reduction rates, the novel PUFAKD exhibited poorer compliance and more pronounced adverse effects compared to CKD. CKD remained a superior choice over the novel PUFAKD in the management of paediatric refractory epilepsy. More controlled trials with varying PUFA compositions are recommended for long-term evaluations.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diet, Ketogenic / Fatty Acids, Unsaturated / Drug Resistant Epilepsy Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Epilepsy Res Journal subject: CEREBRO / NEUROLOGIA Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diet, Ketogenic / Fatty Acids, Unsaturated / Drug Resistant Epilepsy Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Epilepsy Res Journal subject: CEREBRO / NEUROLOGIA Year: 2024 Document type: Article Country of publication: